Rubodex Herbal Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-12-2024
- Paid Up Capital ₹ 0.10 M
as on 29-12-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 M
as on 29-12-2024
- Revenue 26.64%
(FY 2022)
- Profit 111.14%
(FY 2022)
- Ebitda 110.73%
(FY 2022)
- Net Worth 2.52%
(FY 2022)
- Total Assets 18.75%
(FY 2022)
About Rubodex Herbal
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 M.
Charu Dhawan and Rajiv Dhawan serve as directors at the Company.
- CIN/LLPIN
U74899DL1993PTC055940
- Company No.
055940
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rubodex Herbal Private Limited offer?
Rubodex Herbal Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Herbal Body Care Cosmetics, Baby Oil, Baby Body Oils, Hair Oil, Herbal Hair Oil, Cosmetic, Ayurvedic Shampoo, Herbal Foods Beverages, Herbal Diet Pill.
Who are the key members and board of directors at Rubodex Herbal?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Charu Dhawan | Director | 05-Nov-1993 | Current |
Rajiv Dhawan | Director | 12-Feb-2007 | Current |
Financial Performance of Rubodex Herbal.
Rubodex Herbal Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.64% increase. The company also saw a substantial improvement in profitability, with a 111.14% increase in profit. The company's net worth moved up by a moderate rise of 2.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rubodex Herbal?
In 2022, Rubodex Herbal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 11 Nov 2024 | ₹0.60 M | Open |
Hdfc Bank Limited Creation Date: 16 Oct 2023 | ₹0.50 M | Open |
How Many Employees Work at Rubodex Herbal?
Unlock and access historical data on people associated with Rubodex Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rubodex Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rubodex Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.